Unidad de Investigación Biomédica 02, Hospital de Especialidades, Centro Médico Nacional de Occidente
Guadalajara, Jalisco, 44298, Mexico
NCT Number: NCT07008131
Renal transplantation is the renal replacement therapy of choice in patients with end-stage chronic kidney disease. Major urological complications such as urinary leakage, ureteral stricture and urinary tract infections are usually observed in the first three months post-transplantation and lead to higher morbidity and mortality and lower graft function.
To evaluate the use of the double J catheter on major urological complications in extravesical ureteroneocystostomy in renal recipients.
Open clinical trial. Renal transplant recipients were included, who underwent extravesical ureteroneocystostomy with trans-surgical placement of double J catheter compared to extravesical ureteroneocystostomy without trans-surgical catheter placement. The study variables were urinary leakage, ureteral stricture, urinary tract infection, surgical complications and graft function.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Guadalajara, Jalisco, 44298, Mexico
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Extravesical ureteroneocystostomy with double J-catheter placement
Extravesical ureteroneocystostomy with no Double J stent colocation
Time frame: From enrollment to three months
Urinary leakage, uretheral stenosis and urinary infection
Instituto Mexicano del Seguro Social
Other Gov
Impact on Major Urologic Complications With Prophylactic Use of Double J Catheter in Extravesical Ureteroneocystostomy in Renal Transplant Recipients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07700563
Antibody Mediated Rejection, BK Virus Nephropathy
View Trial DetailsNCT05456243
Kidney Transplant
Rochester, Minnesota, United States
View Trial DetailsNCT07621835
CMV Reactivation, CMV Specific Immune Response
Córdoba, Spain
View Trial DetailsNCT04969757
Kidney Transplant
Paris, France
View Trial Details